WatchGov

Texas bills · 89th Legislature (2025)

Texas SB 2308

Relating to the establishment of a consortium to conduct United States Food and Drug Administration's drug development clinical trials with ibogaine to secure the administration's approval of the medication's use for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy and to the administration of that treatment.

  1. Introduced
  2. In committee
  3. Passed Senate
  4. Passed House
  5. To Governor
  6. Became law

Sponsors

Cosponsors (30)

Summary

No official summary is available for this bill.

Latest action(Jun 11, 2025): Effective immediately

Read the official text

Text versions

Roll-call votes

State vote data last updated Oct 15, 2026, 8:06 AM.

DateVoteResultYour legislators
Jun 1, 2025
House
passagepassSet your home in Texas to see
Jun 1, 2025
Senate
passagepassSet your home in Texas to see
May 31, 2025
Senate
passagepassSet your home in Texas to see
May 13, 2025
House
passagepassSet your home in Texas to see
May 12, 2025
House
passagepassSet your home in Texas to see
Apr 30, 2025
Senate
passagepassSet your home in Texas to see
Apr 30, 2025
Senate
Senate Rule 7.18 and the Constitutional Rule requiring bills to be read on three several days be suspended and that SB 2308 be placed on its third reading and final passage.passSet your home in Texas to see

Actions